Artiva Price To Sales Ratio from 2010 to 2024
| ARTV Stock | 11.04 0.64 6.15% |
Price To Sales Ratio | First Reported 2010-12-31 | Previous Quarter 3.35168398 | Current Value 3.18 | Quarterly Volatility 37.82671008 |
Check Artiva Biotherapeutics, financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Artiva Biotherapeutics,'s main balance sheet or income statement drivers, such as Net Interest Income of 2.7 M, Interest Income of 2.7 M or Depreciation And Amortization of 2.4 M, as well as many indicators such as Price To Sales Ratio of 3.18, Dividend Yield of 0.0 or Days Sales Outstanding of 18.2. Artiva financial statements analysis is a perfect complement when working with Artiva Biotherapeutics, Valuation or Volatility modules.
Artiva | Price To Sales Ratio |
Latest Artiva Biotherapeutics,'s Price To Sales Ratio Growth Pattern
Below is the plot of the Price To Sales Ratio of Artiva Biotherapeutics, Common over the last few years. Price to Sales Ratio is figured by comparing Artiva Biotherapeutics, stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Artiva Biotherapeutics, sales, a figure that is much harder to manipulate than other Artiva Biotherapeutics, Common multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. It is a valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period. Artiva Biotherapeutics,'s Price To Sales Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Artiva Biotherapeutics,'s overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 103.10 X | 10 Years Trend |
|
Price To Sales Ratio |
| Timeline |
Artiva Price To Sales Ratio Regression Statistics
| Arithmetic Mean | 87.60 | |
| Geometric Mean | 62.45 | |
| Coefficient Of Variation | 43.18 | |
| Mean Deviation | 28.47 | |
| Median | 105.39 | |
| Standard Deviation | 37.83 | |
| Sample Variance | 1,431 | |
| Range | 102 | |
| R-Value | (0.69) | |
| Mean Square Error | 801.33 | |
| R-Squared | 0.48 | |
| Significance | 0 | |
| Slope | (5.86) | |
| Total Sum of Squares | 20,032 |
Artiva Price To Sales Ratio History
About Artiva Biotherapeutics, Financial Statements
Artiva Biotherapeutics, investors use historical fundamental indicators, such as Artiva Biotherapeutics,'s Price To Sales Ratio, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Artiva Biotherapeutics,. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Price To Sales Ratio | 3.35 | 3.18 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Artiva Stock Analysis
When running Artiva Biotherapeutics,'s price analysis, check to measure Artiva Biotherapeutics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Artiva Biotherapeutics, is operating at the current time. Most of Artiva Biotherapeutics,'s value examination focuses on studying past and present price action to predict the probability of Artiva Biotherapeutics,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Artiva Biotherapeutics,'s price. Additionally, you may evaluate how the addition of Artiva Biotherapeutics, to your portfolios can decrease your overall portfolio volatility.